Third Harmonic Bio Discounted Cash Flow

Third Harmonic Bio (THRD) currently reports a DCF fair value of $6.8. Use the charts on this page to explore Third Harmonic Bio's DCF fair value history and peer comparisons.

Third Harmonic Bio's discounted cash flow (DCF) fair value estimate is $6.8, about 25.5% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.

Start with the current DCF fair value of $6.8, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Third Harmonic Bio, and consider following THRD for alerts when major investors trade the stock.